SHORT-TERM EFFICACY OF TRANSARTERIAL CHEMOEMBOLIZATION WITH EPIRUBICIN-LOADED SUPERABSORBENT POLYMER MICROSPHERES FOR HEPATOCELLULAR CARCINOMA: COMPARISON WITH CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION

被引：0
作者：
Morimoto, M. [1 ]
Kobayashi, S. [1 ]
Moriya, S. [1 ]
Ueno, M. [1 ]
Teduka, S. [1 ]
Ohkawa, S. [1 ]
机构：
[1] Kanagawa Canc Ctr, Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01332-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-083
引用
收藏
页码：S696 / S696
页数：1
相关论文
共 50 条
  • [21] Transarterial Chemoembolization of Hepatocellular Carcinoma with Oncozene Microspheres: An Initial, Short-Term Clinical Experience-A Retrospective, Matched, Comparison Study
    Hung, Matthew L.
    Jiang, Jerry
    Trieu, Harry
    Hao, Frank
    Eghbalieh, Navid
    Ding, Peng-Xu
    Lee, Edward Wolfgang
    [J]. LIFE-BASEL, 2021, 11 (07):
  • [22] Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres and conventional transarterial chemoembolization as first-line treatment in hepatocellular carcinoma patients
    Ma, Yilong
    Zhao, Chang
    Zhao, Hui
    Li, Haiping
    Chen, Changyong
    Xiang, Hua
    Zheng, Chuansheng
    Ma, Cong
    Luo, Chao
    Qiu, Huaiming
    Yao, Yuanhui
    Hu, Hongyao
    Xiong, Bin
    Zhou, Jun
    Zhu, Hui
    Long, Qingyun
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (12): : 7456 - 7470
  • [23] Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres(R) Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis
    Liang, Bin
    Makamure, Joyman
    Shu, Shenglei
    Zhang, Lijie
    Sun, Tao
    Zheng, Chuansheng
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
    Baur, Johannes
    Ritter, Christian O.
    Germer, Christoph-Thomas
    Klein, Ingo
    Kickuth, Ralph
    Steger, Ulrich
    [J]. HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2016, 8 : 69 - 74
  • [25] Conventional transarterial chemoembolization versus doxorubicin bead transarterial chemoembolization for the treatment of hepatocellular carcinoma, a retrospective cohort study
    Bloom, Stephen
    Cheng, Richard Kai Yuan
    Lim, Lucy
    Gow, Paul
    Lubel, John S.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 70 - 71
  • [26] Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres
    Hetta, Waleed M.
    Shebria, Naglaa
    [J]. EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2014, 45 (03) : 761 - 769
  • [27] Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma
    Ferrer Puchol, M. D.
    la Parra, C.
    Esteban, E.
    Vano, M.
    Forment, M.
    Vera, A.
    Cosin, O.
    [J]. RADIOLOGIA, 2011, 53 (03): : 246 - 253
  • [28] Comparison of treatment response, survival and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres versus conventional transarterial chemoembolization in treating hepatocellular carcinoma
    Zhao, Chang
    Pei, Shenglin
    Chen, Zuyi
    Ma, Yilong
    [J]. JOURNAL OF BUON, 2019, 24 (03): : 1150 - 1166
  • [29] Comparison of two Transarterial Chemoembolization Strategies for Hepatocellular Carcinoma
    Tavernier, Jerome
    Fagnoni, Philippe
    Chabrot, Pascal
    Guiu, Boris
    Vadot, Lucie
    Aho, Serge
    Boyer, Louis
    Abergel, Armand
    Hillon, Patrick
    Sautou, Valerie
    Boulin, Mathieu
    [J]. ANTICANCER RESEARCH, 2014, 34 (12) : 7247 - 7253
  • [30] Conventional transarterial chemoembolization followed by irreversible electroporation for hepatocellular carcinoma
    Zhao, Meng
    Li, Fubao
    Tian, Chuan
    Cai, Duo
    Wang, Congxiao
    [J]. BMC CANCER, 2025, 25 (01)
12345